Binding mechanism of luteolin on TiO2 nanocrystals for drug delivery: An integrated experimental and DFT study
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Chemical and Physical Properties of Materials · Extraction and Separation Processes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Unveiling the power of pharmaceutical sciences from molecules to medicines
2. Modern drug research and its impact on pharmaceutical industries
3. A review on integrative approaches in oncology: bridging ayurvedic medicine and modern cancer therapeutics10.3389/fntpr.2025.1635197 ↗
4. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics10.1016/j.gendis.2022.02.007 ↗
5. Beyond chemotherapies: recent strategies in breast cancer treatment10.3390/cancers12092634 ↗
6. Ginsberg · 2014
7. Pharmacokinetics and biodistribution of nanoparticles10.1021/mp800049w ↗
8. Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective10.1080/10717544.2023.2288797 ↗
9. Enhancement of EPR effect for passive tumor targeting: current status and future perspectives10.3390/app15063189 ↗
10. Active targeting drug delivery nanocarriers: ligands
11. Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare10.3390/pharmaceutics16030332 ↗
12. Anticancer phytochemicals of 21st century: a multitargeted approach and role of humanism in oncology
13. Luteolin
14. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin10.1055/s-0028-1088314 ↗
15. Immunopharmacological activities of luteolin in chronic diseases10.3390/ijms24032136 ↗
16. Traditional medicine herbs as natural product matrices in cancer chemoprevention: a trans pharmacological perspective (scoping review)10.1002/ptr.7747 ↗
17. Luteolin, a potent anticancer compound: from chemistry to cellular interactions and synergetic perspectives10.3390/cancers14215373 ↗
18. Regulation of cell cycle progression by growth factor-induced cell signaling10.3390/cells10123327 ↗
19. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers10.1038/s41419-020-02998-6 ↗
20. Potential strategies for overcoming drug resistance pathways using propolis and its polyphenolic/flavonoid compounds in combination with chemotherapy and radiotherapy10.3390/nu16213741 ↗
21. Insights into drug discovery from natural medicines using reverse pharmacokinetics10.1016/j.tips.2014.02.001 ↗
22. Paving luteolin therapeutic potentialities and agro‐food‐pharma applications: emphasis on in vivo pharmacological effects and bioavailability traits10.1155/2021/1987588 ↗
23. The role of uptake and efflux transporters in the disposition of glucuronide and sulfate conjugates10.3389/fphar.2021.802539 ↗
24. Recent developments in luteolin-loaded nanoformulations for enhanced anti-carcinogenic activities: insights from in vitro and in vivo studies10.3390/sci6040068 ↗
25. Transformative impact of nanocarrier‐mediated drug delivery: overcoming biological barriers and expanding therapeutic Horizons10.1002/smsc.202400280 ↗
26. Porosity modification in MOF nanocarriers for pH-Responsive drug delivery in cancer therapy10.1021/acsabm.5c00838 ↗
27. Advancing drug delivery: design and applications of MOF-polyurethane composites for controlled release systems10.1021/acsomega.5c05108 ↗
28. Metal–organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives10.1186/s12951-025-03252-x ↗
29. Photocatalytic advancements and applications of titanium dioxide (TiO2): progress in biomedical, environmental, and energy sustainability
30. Titanium dioxide nanoparticles: prospects and applications in medicine10.3390/nano10020387 ↗
31. Unlocking the potential of titanium dioxide nanoparticles: an insight into green synthesis, optimizations, characterizations, and multifunctional applications10.1186/s12934-024-02609-5 ↗
32. Brookite vs. rutile vs. anatase: whats behind their various photocatalytic activities?10.1016/j.jece.2022.107722 ↗
33. Surface modification of TiO 2 nanoparticles with organic molecules and their biological applications10.1039/D2TB02576K ↗
34. Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
35. Polyethylene glycol immunogenicity in nanomedicine
36. Mini review of TiO2‐based multifunctional nanocomposites for near‐infrared light–responsive phototherapy10.1002/adhm.201800351 ↗
37. Photocatalytic reactive oxygen species production and phototoxicity of titanium dioxide nanoparticles are dependent on the solar ultraviolet radiation spectrum10.1002/etc.1916 ↗
38. Remote light‐responsive nanocarriers for controlled drug delivery: advances and perspectives10.1002/smll.201903060 ↗
39. The development of nanocarriers for natural products10.1002/wnan.1967 ↗
40. Modern nanocarriers as a factor in increasing the bioavailability and pharmacological activity of flavonoids10.1134/S0003683822090149 ↗
41. Advances in nanoparticles in targeted drug Delivery-A review. Results in10.1016/j.rsurfi.2025.100529 ↗
42. Regulation of oxidative stress and inflammation caused by drug accumulation in the TME based on EPR-passive strategy and active targeting10.1186/s12645-025-00342-1 ↗
43. Folate receptor alpha—a novel approach to cancer therapy10.3390/ijms25021046 ↗
44. Drug delivery system and in vitro release of luteolin based on magnetic nanocomposite (Fe3O4@ ZIF‐67)10.1049/mnl.2019.0671 ↗
45. Composite hydrogels with included solid-state nanoparticles bearing anticancer chemotherapeutics10.3390/gels9050421 ↗
46. Biomaterials and emerging anticancer therapeutics: engineering the microenvironment10.1038/nrc.2015.3 ↗
47. Association between pH regulation of the tumor microenvironment and immunological state10.3389/fonc.2023.1175563 ↗
48. Deciphering the structure and chemical composition of drug nanocarriers: from bulk approaches to individual nanoparticle characterization10.1002/ppsc.202100022 ↗
49. Evaluating thermogravimetric analysis for the measurement of drug loading in mesoporous silica nanoparticles (MSNs)10.1016/j.tca.2023.179616 ↗
50. Molecular shape and medicinal chemistry: a perspective10.1021/jm900818s ↗
51. Theoretical study of nitrogen, boron, and co-doped (B, N) armchair graphene nanoribbons10.1007/s00894-020-4307-x ↗
52. Influence of the adsorption of toxic agents on the optical and electronic properties of B 12 N 12 fullerene in the presence and absence of an external electric field10.1039/D0NJ01868F ↗
53. Optical properties of SiC nanocages: ab initio study10.1007/s00339-013-7633-3 ↗
54. Surface passivation effects on the electronic and optical properties of 3C-SiC nanocrystals10.1016/j.physb.2014.09.019 ↗
55. First principles study of the electronic and optical properties of GaAs nanoparticles under the influence of external uniform electric field10.1016/j.physleta.2012.07.040 ↗
56. Understanding the prototype catalyst TiO2 surface with the help of density functional theory calculation10.1002/wcms.1686 ↗
57. Donadoni · 2024
58. Computer-aided nanodrug discovery: recent progress and future prospects10.1039/D3CS00575E ↗
59. Thermally stable nanocrystalline TiO2 photocatalysts synthesized via sol− gel methods modified with ionic liquid and surfactant molecules10.1021/cm0615626 ↗
60. Synthesis of nanocrystalline photocatalytic TiO2 thin films and particles using sol–gel method modified with nonionic surfactants10.1016/j.tsf.2005.12.217 ↗
61. Formulation and evaluation of luteolin-loaded nanovesicles: in vitro physicochemical characterization and viability assessment10.1021/acsomega.1c05628 ↗
62. The cytotoxic effects of titanium oxide nanoparticle on MDA-MB-231 and MCF-7 cells
63. The SIESTA method for ab initio order-nmaterials simulation10.1088/0953-8984/14/11/302 ↗
64. Anatase TiO2 with dominant high-energy {001} facets: synthesis, properties, and applications10.1021/cm200597m ↗
65. Absorption and emission of the apigenin and luteolin flavonoids: a TDDFT investigation10.1021/jp9052538 ↗
66. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors10.1080/00268977000101561 ↗
67. Sol–gel synthesis and characterization of Ag and Au nanoparticles in SiO2, TiO2, and ZrO2 thin films10.1111/j.1151-2916.2000.tb01566.x ↗
68. Infrared intensity-carrying modes and electron− vibration interactions in the radical cations of polycyclic aromatic hydrocarbons10.1021/jp990368m ↗
69. Nanocrystalline TiO2 studied by optical, FTIR and X-ray photoelectron spectroscopy: correlation to presence of surface states10.1016/S0040-6090(99)00722-1 ↗
70. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets10.1021/js9802291 ↗
71. Drug loading methods and kinetic release models using of mesoporous silica nanoparticles as a drug delivery system: a review10.1016/j.sajce.2024.08.013 ↗
72. Salli · 2024